Tue, November 3, 2020

Gregory Renza Initiated (SPRB) at Buy and Held Target at $28 on, Nov 3rd, 2020

Gregory Renza of RBC Capital, Initiated "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $28 on, Nov 3rd, 2020.

Gregory, nor any peers, have made any analyst calls on SPRB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30